With an income increase of 34.33% in the second quarter 2026, year on year to cumulative value of $706 million, and with 2,000 employees, Neurocrine Biosciences Inc 's income per employee grew on trailing twelve month basis to $ 352,750, this marks a new company high for all of 2,000 employees.
The Healthcare sector has seen employees of 14 other companies achieving higher income per employee. While Neurocrine Biosciences Inc 's total ranking has deteriorated compared to the previous quarter from 400 to 413.

What is Income per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Net Income per Employee▼

None ▼

Net Income per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NBIX Net Income per Employee	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Net Income Change	34.33 %	2405.06 %	49.08 %	61.4 %	65.38 %
Net Income per Employee (TTM) $	352,750	334,300	239,300	214,000	174,150
NBIX's Total Ranking	# 413	# 400	# 303	# 410	# 400
Seq. Net Income Change	-27.03 %	28.76 %	-26.63 %	94.88 %	1260.76 %

NBIX Company Profile >> Back to NBIX Efficiency Comparisons >> Compare NBIX Net Income per Employee to its Competitors

NBIX Net Income per Employee Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 15
Healthcare Sector	# 55
Overall Market	# 413

Net Income per Employee Statistics
High	Average	Low
$ 352,750	$ 49,485	$ -109,929
(Jun 30 2026)		(Jun 30 2017)

Companies with similar Income per Employee for 12 month ending Jun 30 2026, within Healthcare Sector	Income per Employee	Income 12 month ending Jun 30 2026	Number of Employees Jun 30 2026
Protagonist Therapeutics inc	616,272.73	$ 81.348 Million	132
Theravance Biopharma inc	597,866.67	$ 53.808 Million	90
Vaxart Inc	593,676.92	$ 38.589 Million	65
Glucotrack Inc	554,600.00	$ 8.319 Million	15
Eli Lilly And Company	534,224.00	$ 26,711.200 Million	50,000
Silexion Therapeutics Corp	489,714.29	$ 6.856 Million	14
Sanuwave Health Inc	488,872.73	$ 26.888 Million	55
Acadia Pharmaceuticals Inc	476,796.99	$ 380.484 Million	798
Biolife Solutions Inc	374,070.97	$ 57.981 Million	155
Indivior Pharmaceuticals Inc	356,000.00	$ 356.000 Million	1,000
Neurocrine Biosciences Inc	352,750.00	$ 705.500 Million	2,000
Jazz Pharmaceuticals Plc	325,523.53	$ 940.763 Million	2,890
Alnylam Pharmaceuticals Inc	323,195.20	$ 807.988 Million	2,500
Spero Therapeutics Inc	295,320.00	$ 7.383 Million	25
Eton Pharmaceuticals Inc	288,363.64	$ 12.688 Million	44
Bristol myers Squibb Company	285,353.85	$ 9,274.000 Million	32,500
Regeneron Pharmaceuticals Inc	280,902.01	$ 4,328.700 Million	15,410
Adma Biologics Inc	261,139.10	$ 168.957 Million	647
Siga Technologies Inc	247,213.16	$ 12.113 Million	49
Interpace Biosciences Inc	239,676.47	$ 24.447 Million	102
Lantheus Holdings Inc	230,766.97	$ 275.305 Million	1,193
Entrada Therapeutics Inc	222,888.16	$ 33.879 Million	152
Lensar Inc	219,520.00	$ 32.928 Million	150
Standard Biotools Inc	218,267.35	$ 84.906 Million	389
Meiragtx Holdings Plc	195,858.56	$ 78.931 Million	403
Intuitive Surgical Inc	185,529.64	$ 3,157.900 Million	17,021
Zoetis Inc	180,413.79	$ 2,616.000 Million	14,500

Date modified: 2026-08-31T07:05:19+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.